News Video | Policy | GPs | Hospitals | Medical | Mental Health | Welfare | Search

 

New Year, new drug for arthritis patients

5 December 2005

New Year, new drug for arthritis patients

People with severe rheumatoid arthritis will have a new subsidised treatment in the New Year following a decision by government drug-funding agency PHARMAC.

The new generation arthritis treatment adalimumab (Humira), one of the TNF alpha inhibitor drugs, will be fully funded for people with severe rheumatoid arthritis from 1 January 2006.

The listing of adalimumab is a significant investment, in the region of $35 million over five years.

PHARMAC Chief Executive Wayne McNee says TNF alpha inhibitors can make a significant difference to the quality of life for people with arthritis.

"For some people with rheumatoid arthritis this can have enormous benefits in enabling them to become more active again," Wayne McNee says.

"We have been working to see at least one of these drugs funded, and this has now been made possible through our agreement with Abbott Laboratories."

PHARMAC estimates that initially a small number of patients will be prescribed adalimumab, but that this group will grow to nearly 1000 people per year after five years. Access to adalimumab will be carefully targeted with access criteria similar to those in Australia.

"Many people already obtain good results from using medicines such as methotrexate or leflunomide, which attack the underlying causes of rheumatoid arthritis," Wayne McNee says. "However, for a small number of patients these medicines aren't sufficient so a TNF alpha inhibitor can make a real difference."

PHARMAC already subsidises one TNF alpha inhibitor, etanercept, for juvenile rheumatoid arthritis. Etanercept will continue to be available to those patients.

ENDS

© Scoop Media

 
 
 
Culture Headlines | Health Headlines | Education Headlines

 


Howard Davis: Joel Coen's Monochromatic Macbeth

The Bard of Avon may well be smirking up the sleeves of his lace doublet at the irony of Will Smith's Oscar debacle, but now that the initial furore has dissipated, it's worth revisiting the movie for which Denzel Washington was also nominated. More>>

Howard Davis: Kenneth Branagh’s Black & White Belfast

Branagh has assembled a wonderful cast, including Ciarán Hinds, a gently formidable actor who well deserves his Oscar nomination, and Judi Dench, who steals every scene she’s in. More>>


Howard Davis: Dennis Villeneuve’s Dune - A Brief History

So many elements of Herbert’s novel have since become tropes of popular SciFi that Villeneuve’s film sometimes seems deceptively derivative. What makes all this nonsense essential viewing is his astonishing visual sensibility. More>>


Howard Davis: Jill Trevelyan's Rita Angus

Although Angus has become one of Aotearoa’s best-loved painters, the story of her life remained little known and poorly understood before Jill Trevelyan's acclaimed and revelatory biography, which has been republished by Te Papa press. More>>

 
 
 
 
 
 

LATEST HEADLINES

  • CULTURE
  • HEALTH
  • EDUCATION
 
 
  • Wellington
  • Christchurch
  • Auckland